📰 Iagnostics News
Page 98 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
March 18, 2022
Researchers develop two SARS-CoV-2 Mutation Discrimination assays that have been designed to detect 501 and 484 mutations on the spike protein.
March 18, 2022
After the start of the SARS-C0V-2 pandemic, investigators from ResearchPath LLC and their collaborators at Rutgers University quickly dedicated resources to develop accurate and reliable COVID-19 testing.
March 17, 2022
DGAP-News: SphingoTec GmbH / Key word(s): Agreement/Development of Sales SphingoTec and Rivaara Labs Close Exclusive Distribution Agreement for Point of Care Diagnostics in India 17.03.2022 / 10:00 The issuer is solely responsible for the content of this announcement. The collaboration focuses o...
March 17, 2022
Researchers utilize variant-specific RT-qPCR assays to monitor wastewater to monitor the prevalence of the Omicron and Delta variants.
March 17, 2022
Clinical stage oncology drug company Avacta has announced the acquisition of its Animal Health division by Vimian Group AB (Vimian. Click to read more...
March 17, 2022
DGAP-News: SphingoTec GmbH / Key word(s): Agreement/Development of Sales SphingoTec and Rivaara Labs Close Exclusive Distribution Agreement for Point of Care Diagnostics in India 17.03.2022
March 17, 2022
The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive prognostic tool.
March 17, 2022
LINKÖPING, Sweden, March 17, 2022 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a digital pathology contract with Erasmus University
March 17, 2022
In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences company) about the possibilities lateral flow assays offer in the post-covid healthscape.
March 17, 2022
World's First 15-minute, Instrument-free, Lab-Quality Molecular Test Available Now Global molecular diagnostics innovator, Sense Biodetection (Sense), announced today that it had entered into a strategic